Pear Therapeutics to Participate in Citi Private Company Digital Health Conference
BOSTON & SAN FRANCISCO–(BUSINESS WIRE)–Pear Therapeutics, Inc. today announced that Chris Guiffre, J.D., M.B.A., Chief Financial Officer and Chief Operating Officer, will participate in a panel discussion at the Citi Private Company Digital Health Conference. The virtual panel discussion, “The Digitization of Therapies,” will take place on Thursday, May 20 at 2:00 p.m. ET.
Pear Therapeutics is a privately held, prescription digital therapeutics company developing clinically validated, FDA-authorized software applications to treat serious disease.
About Pear Therapeutics
Pear Therapeutics is the leader in prescription digital therapeutics, or PDTs. Pear aims to redefine medicine by discovering, developing, and delivering…